NCT00024258View on ClinicalTrials.gov

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2001

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell TumorKidney CancerLiver CancerNeuroblastomaOvarian CancerRetinoblastomaSarcoma
Interventions
DRUG

arsenic trioxide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00024258 - Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors | Biotech Hunter | Biotech Hunter